Skip to the content
ClearNote Health logologo darklogo light
  • Our Story
    • About Us
    • Leadership Team
    • FAQs
    • Careers
  • Our Approach
    • Epigenomics Platform
    • Clinical Trials
    • Publications
  • Our Products
    • Biopharma
    • Pancreatic Cancer
    • Ovarian Cancer
  • Our News
  • Contact Us
  • Order Test
Search
ClearNote Health logo
  • Our Story
    • About Us
    • Leadership Team
    • FAQs
    • Careers
  • Our Approach
    • Epigenomics Platform
    • Clinical Trials
    • Publications
  • Our Products
    • Biopharma
    • Pancreatic Cancer
    • Ovarian Cancer
  • Our News
  • Contact Us
  • Order Test
ClearNote Health logo
  • Our Story
    • About Us
    • Leadership Team
    • FAQs
    • Careers
  • Our Approach
    • Epigenomics Platform
    • Clinical Trials
    • Publications
  • Our Products
    • Biopharma
    • Pancreatic Cancer
    • Ovarian Cancer
  • Our News
  • Contact Us
  • Order Test
HomeEvent
Event

Meet Us at ASCO 2026

ClearNote Health
May 28, 2026
Event

ESMO | Oct 17-21, 2025 | Berlin, Germany

cnhnewcorpdev
October 17, 2025
Event

17th Annual Next Generation Summit | Aug 18-20, 2025 | Washington, D.C.

cnhnewcorpdev
July 29, 2025
Event

15th Annual World Biomarker & CDx Summit | September 22-25, 2025 | Boston, MA

cnhnewcorpdev
July 16, 2025
Event

ASCO 2025 – Poster Presentation

cnhnewcorpdev
May 29, 2025
Event

Digestive Disease Week 2025, May 4–6, San Diego, CA

cnhnewcorpdev
April 29, 2025
Event

AACR Annual Meeting 2025, April 25-30, Chicago

cnhnewcorpdev
March 24, 2025
Event

2025 ACMG Annual Clinical Genetics Meeting | March 18-22, Los Angeles

cnhnewcorpdev
February 27, 2025
Event

TRI-CON 2025 | March 11-13, San Diego

cnhnewcorpdev
February 27, 2025
Event

American Society of Clinical Oncology (ASCO) GU25 | February 13-15

cnhnewcorpdev
February 18, 2025

Posts pagination

1 2 3 4

Meet Us at ASCO 2026

ClearNote Health
May 28, 2026

ClearNote Health Secures $52 Million in Series D Financing and Strengthens Leadership Team to Accelerate Growth in Early Cancer Detection

ClearNote Health
May 27, 2026

Follow us
ClearNote Health logo

Empowering early cancer detection.

Order Test
Company
  • About Us
  • Leadership Team
  • Our News
  • Careers
  • Contact Us
Solutions
  • Avantect Pancreatic Cancer Test
  • Avantect Ovarian Cancer Test
  • Virtuoso Epigenomics Platform
Stay Informed

Get the latest research and announcements from ClearNote Health. Follow us:

Important information: 
The Virtuoso platform is for research use only. Not for use in diagnostic procedures. The Avantect Pancreatic and Ovarian Cancers Tests are early detection tests. The tests do not establish a diagnosis of pancreatic cancer or ovarian cancer, respectively, and results should be considered in the context of other clinical criteria.

Cancer statistics quoted on this website are taken from the CDC and SEER websites, 2025 data.

©2026 ClearNote Health, All Rights Reserved.

Avantect and Virtuoso are trademarks of ClearNote Health. Other trademarks are the property of their respective owners.

  • Privacy Policy
  • Terms of Use
  • Billing rights & protections
  • Cookie Preferences